CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 4.06 USD 4.1% Market Closed
Market Cap: 687.9m USD

Intrinsic Value

The intrinsic value of one CTMX stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.06 USD, CytomX Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTMX Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
CytomX Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

CTMX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CTMX usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CTMX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CTMX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CytomX Therapeutics Inc.

Explain Valuation
Compare CTMX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CTMX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CytomX Therapeutics Inc

Current Assets 149.2m
Cash & Short-Term Investments 143.6m
Receivables 1.6m
Other Current Assets 4m
Non-Current Assets 9m
PP&E 6.5m
Intangibles 1.4m
Other Non-Current Assets 1.1m
Current Liabilities 41m
Accounts Payable 646k
Accrued Liabilities 17.9m
Other Current Liabilities 22.5m
Non-Current Liabilities 9.8m
Other Non-Current Liabilities 9.8m
Efficiency

Free Cash Flow Analysis
CytomX Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CytomX Therapeutics Inc

Revenue
113.6m USD
Operating Expenses
-90.4m USD
Operating Income
23.2m USD
Other Expenses
4.8m USD
Net Income
28m USD
Fundamental Scores

CTMX Profitability Score
Profitability Due Diligence

CytomX Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

CytomX Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CTMX Solvency Score
Solvency Due Diligence

CytomX Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

CytomX Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTMX Price Targets Summary
CytomX Therapeutics Inc

Wall Street analysts forecast CTMX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTMX is 7.21 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Lowest
Price Target
6.06 USD
49% Upside
Average
Price Target
7.21 USD
78% Upside
Highest
Price Target
10.5 USD
159% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

CytomX Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTMX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CTMX Insider Trading
Buy and sell transactions by insiders

CTMX News

What is the Intrinsic Value of one CTMX stock?

The intrinsic value of one CTMX stock under the Base Case scenario is hidden USD.

Is CTMX stock undervalued or overvalued?

Compared to the current market price of 4.06 USD, CytomX Therapeutics Inc is hidden .

Back to Top